A crucial role for thiol antioxidants in estrogen-deficiency bone loss

Journal of Clinical Investigation

Volumn 112, Issue 6, 2003, Pages 915-923

  Lean, Jenny M ^a   Davies, Julie T ^a   Fuller, Karen ^a   Jagger, Christopher J ^a   Kirstein, Barrie ^a   Partington, Geoffrey A ^a   Urry, Zoë L ^a   Chambers, Timothy J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; COLONY STIMULATING FACTOR 1; CYTOKINE; DNA; ESTRADIOL; ESTROGEN; GLUTATHIONE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; THIOREDOXIN; THIOREDOXIN REDUCTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIMETABOLITE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; GENE EXPRESSION; HORMONE ACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; ANIMAL; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; FEMUR; METABOLISM; OSTEOBLAST; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTIMETABOLITES; ANTIOXIDANTS; BONE MARROW CELLS; BONE RESORPTION; BUTHIONINE SULFOXIMINE; CELLS, CULTURED; ESTRADIOL; ESTROGENS; FEMALE; FEMUR; GLUTATHIONE; GLUTATHIONE REDUCTASE; MICE; OSTEOBLASTS; OVARIECTOMY; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; THIOREDOXIN;

EID: 0142186681     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318859     Document Type: Article

References (49)

1. Riggs, B.L., Khosla, S., and Melton, L.J., III. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 23:279-302.
2. Shevde, N.K., Bendixen, A.C., Dienger, K.M., and Pike, J.W. 2000. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc. Natl. Acad. Sci. U. S. A. 97:7829-7834.
3. Parikka, V., et al. 2001. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology. 142:5371-5378.
4. Srivastava, S., et al. 2001. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL-induced JNK activation. J. Biol. Chem. 276:8836-8840.
5. Eghbali-Fatourechi, G., et al. 2003. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111:1221-1230. doi:10.1172/JCI200317215.
6. Hofbauer, L.C., et al. 1999. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 140:4367-4370.
7. Manologas, S.C., Kousteni, S., and Jilka, R.L. 2002. Sex steroids and bone. Recent Prog. Horm Res. 57:385-409.
8. Pfeilschifter, J., Koditz, R., Pfohl, M., and Schatz, H. 2002. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23:90-119.
9. Sack, M.N., Rader, D.J., and Cannon, R.O. 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:269-270.
10. Sudoh, N., et al. 2001. Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation. 103:724-729.
11. Arnal, J.F., et al. 1996. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. U. S. A. 93:4108-4113.
12. Sawada, H., et al. 2000. Mechanisms of antiapoprotic effects of estrogens in nigral dopaminergic neurons. FASEB J. 14:1202-1214.
13. Dröge, W. 2002. Free radicals in the physiological control of cell function. Physiol. Rev. 92:47-95.
14. Haddad, J.J. 2002. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal. 14:879-897.
15. Paolicchi, A., Dominici, S., Pieri, L., Maellaro, E., and Pompella, A. 2002. Glutathione catabolism as a signaling mechanism. Biochem. Pharmacol. 64:1027-1035.
16. Meister, A. 1994. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269:9397-9400.
17. Bax, B.E., et al. 1992. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem. Biophys. Res. Comm. 183:1153-1158.
18. Garrett, I.R., et al. 1990. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85:632-639.
19. Finkel, T., and Holbrook, N.J. 2000. Oxidants, oxidative stress and the biology of ageing. Nature. 408:239-247.
20. Steinbeck, M.J., Appel, W.H., Jr., Verhoeven, A.J., and Karnovsky, M.J. 1994. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J. Cell Biol. 126:765-772.
21. Dickinson, D.A., and Forman, H.J. 2002. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 64:1019-1026.
22. Danon, A. 2002. Redox reactions of regulatory proteins: do kinetics promote specificity? Trends Biochem. Sci. 27:197-203.
23. Tietze, F. 1969. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:502-522.
24. Baker, M.A., Cerniglia, G.J., and Zaman, A. 1990. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190:360-365.
25. Holmgren, A., and Björnstedt, M. 1995. Thioredoxin and thioredoxin reductase. Methods. Enzymol. 252:199-208.
26. Jain, A., et al. 1992. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung surfactant, and skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 89:5093-5097.
27. Chow, J., Tobias, J.H., Colston, K.W., and Chambers, T.J. 1992. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J. Clin. Invest. 89:74-78.
28. Fuller, K., Murphy, C., Kirstein, B., Fox, S.W., and Chambers, T.J. 2002. TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology. 143:1108-1118.
29. Partington, G.A., and Patient, R.K. 1999. The DNA-binding affinity of GATA-1 is altered by changes in phosphorylation during erythroleukemia cell differentiation. Nucleic Acids Res. 27:1168-1175.
30. Lean, J.M., et al. 2000. Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. Bone. 27:29-40.
31. Jilka, R.L., et al. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:88-91.
32. Kirazawa, R., Kimble, R.B., Vannice, J.L., Kung, V.T., and Pacifici, R. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94:2397-2406.
33. Roggia, C., et al. 2001. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. U. S. A. 98:13960-13965.
34. Garg, A.K., and Aggarwal, B.B. 2002. Reactive oxygen intermediates in TNF signaling. Mol. Immunol. 39:509-517.
35. Lam, J., et al. 2000. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:1481-1488.
36. Sasaki, K., Bannai, S., and Makino, N. 1998. Kinetics of hydrogen peroxide elimination by human umbilical vein endothelial cells in culture. Biochim. Biophys. Acta. 1380:275-288.
37. Mitsui, A., Hirakawa, T., and Yodoi, J. 1992. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Comm. 186:1220-1226.
38. Nordberg, J., and Arnér, E.S.J. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31:1287-1312.
39. 2 upon thioredoxin-enriched lens epithelial cells. J. Biol. Chem. 263:4984-4990.
40. Mody, N., Parhami, F., Sarafian, T.A., and Demer, L.L. 2001. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31:509-519.
41. Gilbert, L., et al. 2002. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by rumor necrosis factor-alpha. J. Biol. Chem. 277:2695-2701.
42. Panagakos, F.S., Fernandez, C., and Kumar, S. 1996. Ultrastructural analysis of mineralized matrix from human osteoblastic cells: effect of tumor necrosis factor-alpha. Mol. Cell. Biochem. 158:81-89.
43. Samoto, H., et al. 2002. TNF-alpha suppresses bone sialoprotin (BSP) expression in ROS17/28 cells. J. Cell Biochem. 87:313-323.
44. Armour, K.E., et al. 2001. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology. 142:760-766.
45. Basu, S., Michaelsson, K., Olofsson, H., Johansson, S., and Melhus, H. 2001. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Comm. 288:275-279.
46. Maggio, D., et al. 2003. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J. Clin. Endocrinol. Metab. 88:1523-1527.
47. Morton, D.J., Barrett-Connor, E.L., and Schneider, D.L. 2001. Vitamin C supplement use and bone mineral density in postmenopausal women. J. Bone Miner. Res. 16:135-140.
48. Tyner, S.D., et al. 2002. p53 mutant mice that display early aging-associated phenotypes. Nature. 415:45-53.
49. de Boer, J., et al. 2002. Premature aging in mice deficient in DNA repair and transcription. Science. 296:1276-1279.